AEC Partners is proud to have supported EverImmune

We are proud to have supported EverImmune in its series A funding, enabling its lead product, Oncobax® AK, to enter the clinical stage in microbiota immuno-oncology

Read Press ReleaseLire le communiqué de presse

AEC Partners is proud to have supported Valbiotis

AEC Partners is proud to have supported Valbiotis with its estimated sizing of the mild to moderate hypertension market.

Read Press ReleaseLire le communiqué de presse